SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 19.35 |
Enterprise Value ($M) | 16.93 |
Book Value ($M) | 6.40 |
Book Value / Share | 0.50 |
Price / Book | 3.02 |
NCAV ($M) | 4.14 |
NCAV / Share | 0.32 |
Price / NCAV | 4.67 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -5.66 |
Return on Assets (ROA) | -0.74 |
Return on Equity (ROE) | -1.06 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.79 |
Current Ratio | 1.31 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 21.36 |
Assets | 23.63 |
Liabilities | 17.22 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 76.07 |
Operating Income | -10.85 |
Net Income | -57.04 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -8.40 |
Cash from Investing | -0.23 |
Cash from Financing | 3.15 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Starke Clifford | 12.54 | 64.68 | |
13G | Global X Management CO LLC | 12.04 | -2.48 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
51,165 | 152,691 | 33.51 | |
35,014 | 20,285 | 172.61 | |
148,434 | 323,621 | 45.87 | |
110,118 | 39,523 | 278.62 | |
(click for more detail) |
Similar Companies | |
---|---|
FBIO – Fortress Biotech, Inc. | FBRX – Forte Biosciences, Inc. |
FENC – Fennec Pharmaceuticals Inc. | FTLF – FitLife Brands, Inc. |
FWBI – First Wave BioPharma, Inc. |
Financial data and stock pages provided by
Fintel.io